巴里西提尼布:重症脱发区域的审查
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com.
American journal of clinical dermatology
|June 16, 2023
概括
巴里西提尼布是一种简氏激酶 (JAK) 抑制剂,有效地促进严重脱发性白发症的成年人头发的再生. 这种治疗在36周内显示出显著的头皮,眉毛和毛头发再生.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的脱发症是具有挑战性的自身免疫性疾病,经常复发.
- 患者经常经历严重的心理痛苦,包括焦虑和抑郁.
- 现有的治疗严重的白发性脱发症的疗法有效性有限.
研究的目的:
- 评估巴里西提尼布在治疗严重脱发症的有效性和安全性.
- 评估头皮,眉毛和毛区域的头发再生情况.
- 为了确定巴里西提尼布在这个患者群体中的耐受性.
主要方法:
- 进行了两个关键的,安慰剂控制的第三期临床试验.
- 患有严重脱发症的成年患者每天服用一次口服巴里西提尼布.
- 治疗持续时间为36周,并进行持续的安全监测.
主要成果:
- 巴里西丁尼 (Baricitinib) 显示了临床上有意义的头皮,眉毛和毛头发的再生.
- 参与者一般都能很好地忍受这种治疗.
- 常见的不良事件包括感染,头痛,,以及肌酸酸酶水平升高.
结论:
- 巴里西提尼布是一种有效和有用的治疗选择,用于严重的脱发症.
- 需要进一步的长期研究才能充分阐明好处和风险.
- 该药物为患有严重脱发症的患者提供了有前途的治疗进展.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
161
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
161
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
202
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
202
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
177
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
177
Drugs for Treatment of Ulcerative Colitis in IBD
179
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
179
Inflammatory Bowel Disease IV: Pharmacological Management
158
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
158
Autoimmune Disorders
527
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
527


